Physician profile
Adeel Anwar
NPI 1255717609
$3,546.57
in general payments reported to CMS, 2019-2025
13 companies · $434 in 2025
The $434 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.20 · 2020: $396 · 2021: $749 · 2022: $578 · 2023: $946 · 2024: $419 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,798.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $780.74 | 2019-2025 | Aristada, Lybalvi, Vivitrol |
| Janssen Pharmaceuticals, INC | $760.37 | 2020-2025 | Invega Sustenna |
| Otsuka America Pharmaceutical, INC. | $578.17 | 2020-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Neurocrine Biosciences, INC. | $380.59 | 2020-2024 | Ingrezza |
| Bioxcel Therapeutics, INC. | $268.42 | 2023-2024 | Igalmi |
| Teva Pharmaceuticals USA, INC. | $238.92 | 2020-2023 | Uzedy |
| E.R. Squibb & Sons, L.L.C. | $219.03 | 2024-2025 | Cobenfy |
| Lundbeck LLC | $87.19 | 2023-2024 | Abilify Maintena |
| Vanda Pharmaceuticals INC. | $80.91 | 2020 | |
| Indivior INC. | $64.84 | 2024 | Perseris |
| Boston Scientific Corporation | $41.53 | 2025 | Overstitch Endoscopic Suturing System |
| Abbvie INC. | $23.86 | 2025 | |
| Brainsway USA INC | $22.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adeel Anwar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.